Rijuven launched CardioSleeve for Pediatrics, touting it as the first FDA-cleared device that adds ECG capabilities to transform any existing stethoscope into a smart, mobile-connected device with 3-Lead ECG, Digital Auscultation, and real-time digital analysis optimized for pediatric care. Using CardioSleeve, Pediatricians and clinicians can quickly visualize heart sound, analyze for arrhythmia or murmur, and identify heart failure.
Rijuven’s device can even detect advanced murmur at times when restless patients, noisy environments and rapid heart rate can make examinations challenging. CardioSleeve’s analysis aids in the diagnosis of pathological and physiological heart sounds in patients as young as infants, at heart rates up to 180 beats per minute.
CardioSleeve is attached to an existing stethoscope to do its magic, acquiring the digital acoustic and electric footprints of the heart and transmitting them to a mobile device for analysis. This allows for the creation of the Systolic Performance Index, a measure of Ejection Fraction, critical to identifying heart failure.
Using CardioSleeve, Pediatricians and clinicians can quickly visualize heart sound, analyze for arrhythmia or murmur, and identify heart failure.“With CardioSleeve and the i2Dtx platform, Pediatricians now have the power of ECG right on the stethoscopes they already know and love,” said Rijuven President and Co-founder Raj Kapoor, MD, FCCP. “CardioSleeve makes existing stethoscopes smarter so they can do things an ordinary stethoscope can’t: visualize a heart murmur, quickly analyze heart rhythm, and identify heart failure, all while reducing costs and enhancing patient care.”
CardioSleeve for Pediatrics is part of the Rijuven i2Dtx, a portable, cloud-based medical device platform for heart, lung, vital signs, imaging and lab clinical assessments for any physical examination. i2Dtx connects vitals, diagnostic, and lab devices with live notes, real-time consults, HD photos for visual exams and a complete EMR report both in the facility and remotely.